Rowsley says sale price of TMC Life Sciences warrants set at S$34.8m

-A +A

SINGAPORE (March 19): Rowsley says the cash consideration for the warrants of TMC Life Sciences (TMCLS) is set at RM103.75 million (S$34.8 million).

This is derived from the volume weighted average price of TMCLS warrants traded on Bursa Securities for the one-month period to March 19 of RM0.1737 per warrant, multiplied by an aggregate of some 597.3 million TMCLS warrants.

As announced last Dec, Rowsley is acquiring the healthcare businesses of Thomson Medical from controlling shareholder Peter Lim for S$1.6 billion... (Click here to read the full story.)